Assessing Gα

Gα15/16 signaling Inositol phosphate Gαq signaling G-protein-coupled receptor IP-One Seven-transmembrane receptor Signal transduction.

Journal

Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102

Informations de publication

Date de publication:
20 Aug 2020
Historique:
received: 28 04 2020
revised: 15 06 2020
accepted: 16 06 2020
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 5 3 2021
Statut: epublish

Résumé

Cell-based functional assays are an important part of compound screening and drug lead optimization, and they can also play a crucial role in the determination of the residues involved in ligand binding and signaling for a particular G-protein-coupled receptor. Conventional methods used for Gα

Identifiants

pubmed: 33659379
doi: 10.21769/BioProtoc.3715
pii: e3715
pmc: PMC7842692
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e3715

Informations de copyright

Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no known competing financial interests or personal relationships which have, or could be perceived to have, influenced the work reported in this article.

Références

Assay Drug Dev Technol. 2004 Jun;2(3):269-80
pubmed: 15285908
J Biomol Screen. 2007 Mar;12(2):285-7
pubmed: 17289936
Biochem Pharmacol. 2018 Aug;154:104-117
pubmed: 29684376
Nat Rev Drug Discov. 2006 Dec;5(12):993-6
pubmed: 17139284
Sci Adv. 2019 Oct 09;5(10):eaax2518
pubmed: 31633023
Nat Commun. 2019 Dec 6;10(1):5573
pubmed: 31811124
Methods Mol Biol. 2005;306:17-26
pubmed: 15867462
Assay Drug Dev Technol. 2010 Feb;8(1):106-13
pubmed: 19922239
Curr Chem Genomics. 2008 Jul 11;1:70-8
pubmed: 20161830
Sci Rep. 2016 Nov 10;6:36681
pubmed: 27830715
Expert Opin Drug Discov. 2011 Oct;6(10):981-94
pubmed: 22646860

Auteurs

Élie Besserer-Offroy (É)

Dept. of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.

Rebecca L Brouillette (RL)

Dept. of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.

Jean-Michel Longpré (JM)

Dept. of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.

Philippe Sarret (P)

Dept. of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.

Classifications MeSH